Gujarat Themis Biosyn Limited (GUJTHEM) — Insider Trading

· NSE 🔴 High Importance Neutral

Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares from Pharmaceutical Business Group (India) Limited at Rs. 395.75 per share, totaling up to Rs. 20 crores, representing 0.50% of the company's share capital. The transaction, scheduled between 08.07.2026 and 14.07.2026, is an inter-se transfer among promoters and complies with SEBI takeover exemption norms. Post-acquisition, Patel's holding will rise to 2.77% from 2.29%.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,034.98 Cr P/E: 84.4

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day